GEM-SUBSTITUTED HYDROXAMIC ACID

PROBLEM TO BE SOLVED: To provide a geminally disubstituted cyclic hydroxamic acid derivative effective for the therapy of arthritis, cancer and other diseases. SOLUTION: This compound is represented by general formula (I) or a pharmaceutically acceptable salt thereof. Concretely, 4-[4-(4-fluoro-2-me...

Full description

Saved in:
Bibliographic Details
Main Author NOE MARK CARL
Format Patent
LanguageEnglish
Published 13.11.2001
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:PROBLEM TO BE SOLVED: To provide a geminally disubstituted cyclic hydroxamic acid derivative effective for the therapy of arthritis, cancer and other diseases. SOLUTION: This compound is represented by general formula (I) or a pharmaceutically acceptable salt thereof. Concretely, 4-[4-(4-fluoro-2-methyl- benzyloxy)-benzenesulfonyl]-3-hydroxy-tetrahydro-pyrane-3-carboxylic acid hydroxamide is cited as the compound. The compound represented by general formula (I) has activities for inhibiting matrix metalloprotease and an enzyme belonging to the reprolysin subfamily of metzincins, and exhibits therapeutic effects on the wide diseases including the above diseases.
Bibliography:Application Number: JP20010095089